Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 111 of 1714:
101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121
Gene Compound Assay Inh Ic50 Ki View
Cytochrom P450-1A2 monooxygenase DANAZOL CYP450-1A2 Inhibition 35% NoneNone NoneNone View
opioid receptor, delta 1 MIFEPRISTONE Opiate delta 35% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase DIETHYLSTILBESTROL CYP450-2C19 Inhibition 35% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 THIABENDAZOLE Cyclooxygenase COX-2 35% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) THIABENDAZOLE Cyclooxygenase COX-2 35% NoneNone NoneNone View
adrenergic receptor, beta 3 AZAURIDINE Adrenergic beta3 35% NoneNone NoneNone View
phosphodiesterase 3B AZAURIDINE Phosphodiesterase PDE3 35% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
epidermal growth factor receptor RWJ-68354 Protein Tyrosine Kinase, EGF Receptor 34% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase IFOSFAMIDE CYP450-1A2 Inhibition 34% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 GLICLAZIDE Potassium Channel [KATP] 34% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 GLICLAZIDE Potassium Channel [KATP] 34% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 GLICLAZIDE Potassium Channel [KATP] 34% NoneNone NoneNone View
dopamine receptor D4 DIELDRIN Dopamine D4.2 34% NoneNone NoneNone View
acetylcholinesterase (YT blood group) RISPERIDONE Acetylcholinesterase 34% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase RISPERIDONE Acetylcholinesterase 34% NoneNone NoneNone View
acetylcholinesterase RISPERIDONE Acetylcholinesterase 34% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DIELDRIN Serotonin Transporter 34% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) TROPISETRON Adrenergic alpha1D 34% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase HALOPROGIN CYP450-2C19 Inhibition 34% NoneNone NoneNone View
matrix metallopeptidase 9 AZLOCILLIN Protease, Matrix Metalloprotease-9 (MMP-9) 34% NoneNone NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) AZLOCILLIN Protease, Matrix Metalloprotease-9 (MMP-9) 34% NoneNone NoneNone View
adrenergic receptor, alpha 1b D-TUBOCURARINE CHLORIDE Adrenergic alpha1B 34% NoneNone NoneNone View
opioid receptor, sigma 1 KETOTIFEN Sigma1 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 9 D-TUBOCURARINE CHLORIDE Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 10 D-TUBOCURARINE CHLORIDE Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, epsilon polypeptide D-TUBOCURARINE CHLORIDE Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 4 D-TUBOCURARINE CHLORIDE Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 5 D-TUBOCURARINE CHLORIDE Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) D-TUBOCURARINE CHLORIDE Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 DIGOXIN Muscarinic M5 34% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 1 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
AT hook, DNA binding motif, containing 1 (DBSS) SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, theta SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 2 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 2 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 SAQUINAVIR GABAA, Chloride Channel, TBOB 34% NoneNone NoneNone View
A3 adenosine receptor NORETHINDRONE ACETATE Adenosine A3 34% NoneNone NoneNone View
Sigma-2 Receptor BOPINDOLOL Sigma2 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit NORGESTREL Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) GENTIAN VIOLET Adenosine Transporter 34% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 GENTIAN VIOLET Adenosine Transporter 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 LY-294002 Calcium Channel Type L, Phenylalkylamine 34% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B LY-294002 Serotonin 5-HT4 34% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 LY-294002 Serotonin 5-HT4 34% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) MIFEPRISTONE CYP450-2C9 Inhibition 34% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 MIFEPRISTONE CYP450-2C9 Inhibition 34% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 ENALAPRIL Cyclooxygenase COX-2 34% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) ENALAPRIL Cyclooxygenase COX-2 34% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase NIFURSOL CYP450-1A2 Inhibition 34% NoneNone NoneNone View
adrenergic receptor, beta 3 METOPROLOL Adrenergic beta3 34% NoneNone NoneNone View
carbonic anhydrase 4 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase XI 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase IX 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase VIII 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase VII 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase VA, mitochondrial 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase IV 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase III, muscle specific 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase I 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase XIV 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase VB, mitochondrial 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase XII 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase VI 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase II 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase 5a, mitochondrial 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase 3 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
carbonic anhydrase 2 4-OCTYLPHENOL Carbonic Anhydrase 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit MESTRANOL Calcium Channel Type L, Benzothiazepine 34% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase FLUOROMETHOLONE CYP450-2C19 Inhibition 34% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 FLUOROMETHOLONE Cyclooxygenase COX-2 34% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) FLUOROMETHOLONE Cyclooxygenase COX-2 34% NoneNone NoneNone View
adrenergic receptor, beta 1 GUANABENZ Adrenergic beta1 34% NoneNone NoneNone View
adrenergic, beta-1-, receptor GUANABENZ Adrenergic beta1 34% NoneNone NoneNone View
adrenergic receptor, alpha 2b ETHYNODIOL DIACETATE Adrenergic alpha2B 34% NoneNone NoneNone View
opioid receptor, kappa 1 PIPAMAZINE Opiate kappa 34% NoneNone NoneNone View
arginine vasopressin receptor 1A LINCOMYCIN Vasopressin V1A 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 9 EPIRUBICIN Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 10 EPIRUBICIN Nicotinic Acetylcholine, Central 34% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha KETOTIFEN Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta KETOTIFEN Sodium Channel, Site 2 35% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha MOSAPRIDE Sodium Channel, Site 2 35% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 EPERISONE Muscarinic M1 35% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 FLEROXACIN Chemokine CCR5 35% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase BROMOCRIPTINE CYP450-2C19 Inhibition 35% NoneNone NoneNone View
dopamine receptor D4 VERAPAMIL Dopamine D4.2 35% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a GUANFACINE Serotonin 5-HT3 35% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b GUANFACINE Serotonin 5-HT3 35% NoneNone NoneNone View
insulin receptor ETIDRONATE Insulin 35% NoneNone NoneNone View
insulin receptor ETIDRONATE Insulin 35% NoneNone NoneNone View
dopamine receptor D4 MIANSERIN Dopamine D4.2 35% NoneNone NoneNone View
adrenergic receptor, alpha 2b METHYSERGIDE Adrenergic alpha2C 35% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) METHYSERGIDE Adrenergic alpha2C 35% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) MC 258717 CYP450-2C9 Inhibition 35% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 MC 258717 CYP450-2C9 Inhibition 35% NoneNone NoneNone View
arginine vasopressin receptor 1A INDINAVIR Vasopressin V1A 35% NoneNone NoneNone View
leukotriene B4 receptor 2 IDEBENONE Leukotriene B4 35% NoneNone NoneNone View
leukotriene B4 receptor IDEBENONE Leukotriene B4 35% NoneNone NoneNone View
leukotriene B4 receptor IDEBENONE Leukotriene B4 35% NoneNone NoneNone View
leukotriene B4 receptor 2 IDEBENONE Leukotriene B4 35% NoneNone NoneNone View
tachykinin receptor 2 VINCRISTINE Tachykinin NK2 35% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Calcium Channel Type L, Phenylalkylamine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Calcium Channel Type L, Phenylalkylamine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Calcium Channel Type L, Phenylalkylamine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Calcium Channel Type L, Phenylalkylamine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Calcium Channel Type L, Phenylalkylamine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Calcium Channel Type L, Phenylalkylamine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 IDARUBICIN Calcium Channel Type L, Dihydropyridine 35% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel associated protein 1 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel associated protein 2 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta 17-METHYLTESTOSTERONE Sodium Channel, Site 2 35% NoneNone NoneNone View